Method for detecting a brain region with neurodegenerative change
A computerized method is disclosed for detecting a brain region with neurodegenerative change and also a brain region with vascular change in the brain of a patient and also an imaging arrangement suitable for this. In at least one embodiment, the method includes recording a first data record of the brain via positron emission tomography and a second data record of the brain via magnetic resonance imaging; reconstructing a PET image from the first data record and an MRI image from the second data record; identifying evidence for a brain region with vascular change in the MRI image; segmenting the MRI image into gray matter and white matter; identifying a brain region with neurodegenerative change in the PET image; and superposing the PET image and the segmented MRI image to determine whether the brain region with neurodegenerative change is present in gray matter or in white matter, the recording of the first data record and the second data record being carried out in quick succession without repositioning the patient or is even carried out simultaneously.
1. A computerized method for detecting a brain region with neurodegenerative change and also a brain-region with vascular change in the brain of a patient, the computerized method comprising:
recording a positron emission data record of the brain via positron emission tomography and a magnetic resonance data record of the brain via magnetic resonance imaging, the recording of the positron emission data record and the magnetic resonance data record being carried out one of in succession without repositioning the patient, or simultaneously;
reconstructing a PET image from the positron emission data record and an MRI image from the magnetic resonance data record;
identifying evidence for a brain region with vascular change in the MRI image;
segmenting the MRI image into gray matter and white matter;
identifying a brain region with neurodegenerative change in the PET image; and
superposing, in response to observing a changed brain region in the PET image, the PET image and the segmented MRI image to determine whether the identified brain region with neurodegenerative change is present in gray matter or in white matter.
2. The method as claimed in claim 1 , wherein a functional brain region is stimulated during the recording of a functional magnetic resonance data record.
3. The method as claimed in claim 2 , wherein a correction of movement artifacts in the positron emission data record is carried out based on the magnetic resonance data record.
4. The method as claimed in claim 2 , wherein the positron emission data record is subject to a partial volume correction based on the magnetic resonance data record.
5. The method as claimed in claim 2 , wherein an image of the brain region with neurodegenerative change and of the brain region with vascular change is generated.
6. The method as claimed in claim 2 , wherein the brain region with neurodegenerative change and the brain region with vascular change are transferred to the image in different colors.
7. The method as claimed in claim 6 , further comprising:
administering a radioactively marked substance, absorbed specifically by the brain region, with neurodegenerative change.
8. The method as claimed in claim 7 , wherein the substance used is fluoro-18-deoxyglucose or 2-(1-{6-[(2-[fluoro-18]ethyl)(methyl)amino]-2-naphthyl}-ethylidene)malono-nitrile.
9. The method of claim 2 , wherein a correction of movement artifacts in the functional magnetic resonance data record is carried out based on the magnetic resonance data record.
10. The method as claimed in claim 1 , wherein a correction of movement artifacts in the positron emission data record is carried out based on the magnetic resonance data record.
11. The method as claimed in claim 1 , wherein the positron emission data record is subject to a partial volume correction based on the magnetic resonance data record.
12. The method as claimed in claim 1 , wherein an image of the brain region with neurodegenerative change and of the brain region with vascular change is generated.
13. The method as claimed in claim 1 , wherein the brain region with neurodegenerative change and the brain region with vascular change are transferred to the image in different colors.
14. The method as claimed in claim 13 , further comprising:
administering a radioactively marked substance, absorbed specifically by the brain region, with neurodegenerative change.
15. The method as claimed in claim 14 , wherein the substance used is fluoro-18-deoxyglucose or 2-(1-{6-[(2-[fluoro-18]ethyl)(methyl)amino]-2-naphthyl}-ethylidene)malono-nitrile.
16. The method of claim 1 , wherein a correction of movement artifacts in a functional magnetic resonance data record is carried out based on the magnetic resonance data record.
17. A tangible computer readable data storage medium storing computer executable instructions that, when executed, cause a control and evaluation system of an imaging arrangement to carry out the method of claim 1 .
18. A non-transitory computer readable medium including program segments for, when executed on a computer device, causing the computer device to implement the method of claim 1 .